- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02201888
Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study
July 25, 2014 updated by: Salvador Sarró, MD
Schizophrenia is known to be associated with cognitive dysfunction which increasing evidence suggests has consequences for functional adaptation and which cause difficulties in social re-integration after hospitalization.
The investigators propose a large scale, multicentric study (7 centres from the Hermanas Hospitalarias del Sagrado Corazón de Jesús network) aimed at answering outstanding questions concerning the effectiveness of cognitive estimulation therapy for schizophrenic cognitive impairment.
Specifically, the study will examine a) issues related to the size of the effect compared to treatment as usual and compared to a control intervention; b) generalizability of improvement to cognitive function and social cognition in daily life; and c) the durability of therapeutic gains after the end of treatment.
192 patients with chronic schizophrenia will be randomly assigned to one of three treatment conditions: a computer- assisted cognitive estimulation program (n=64), non-structured time on computer (n=64) and treatment as usual (n=64).
A battery of neurocognitive tests of memory and executive function, including 'ecologically valid' measures, will be administered by blind evaluators at baseline, after 6 months of cognitive estimulation, and after 6 months follow-up.
Symptoms, social functioning and self-esteem will be also be assessed at baseline, after the treatment and at follow-up.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08035
- FIDMAG Germanes Hospitalàries Research Foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- schizophrenia or schizoaffective disorder fulfilling the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria diagnosis
- estimated premorbid intelligence quotient (IQ) in the normal range
- chronic illness (i.e. duration ≥two years)
- relative clinical stability (i.e. the patients had not experienced any recent exacerbation of symptoms).
Exclusion Criteria:
- history of brain trauma
- alcohol or substance abuse/dependence within the previous six months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Computer-assisted cognitive training
Patients in this arm of the trial carried out computerized online training drawn from the Feskits program (www.feskits.com),
chosen to have attention, memory and executive function components.
Specifically the sessions included the following exercises: sustained attention (4 minutes), attention/perception (5 minutes), working memory (8 minutes), auditory and visual memory (8 minutes), executive function (10 minutes), language (6 minutes), and games (4 minutes).
|
Treatment lasted six months.
The CRT and CC conditions consisted of biweekly sessions of 45 minutes.
Patients in both conditions trained in groups of up to 8, supervised by a single person.
The CRT and CC groups were scheduled at different times.
The same personnel supervised both treatment conditions.
All supervisors were trained by the coordinator of the study in the technical management of the two conditions.
Other Names:
|
Active Comparator: Computerized active condition
Patients allocated to this condition completed the same number of sessions as the cognitive training group but followed a computerized typing program (www.rapidtyping.com).
This had similar design characteristics to the CRT condition, in that it was hierarchically organized with exercise level of difficulty being adjusted to the individual's level of performance and feedback being given at the end of each exercise.
Additionally, patients in this condition played computerized games requiring typing (crosswords, word puzzles, etc) and were taught basic internet navigation by a supervisor.
Exposure to the computer was of equivalent duration to the CRT condition.
|
Treatment lasted six months.
The CRT and CC conditions consisted of biweekly sessions of 45 minutes.
Patients in both conditions trained in groups of up to 8, supervised by a single person.
The CRT and CC groups were scheduled at different times.
The same personnel supervised both treatment conditions.
All supervisors were trained by the coordinator of the study in the technical management of the two conditions.
Other Names:
|
Placebo Comparator: Treatment as usual
Patients in this condition participated in their (individually variable) daily rehabilitative activities.
Patients allocated to the other two conditions also participated in these activities
|
TAU: Patients in this condition participated in their (individually variable) daily rehabilitative activities.
Patients allocated to the other two conditions also participated in these activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Memory test battery
Time Frame: Six months
|
memory test battery Rivermead Behavioural Memory Test (RBMT)(Wilson, 1985) a memory test battery and the executive test battery, the Behavioural Assessment of the Dysexecutive Syndrome (BADS)(Wilson, 1996)
|
Six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Peter J McKenna, MD, FIDMAG Germanes Hospitalàries Research Foundation
- Principal Investigator: Jesus J Gomar, PhD, FIDMAG Germanes Hospitalàries Research Foundation
- Study Chair: Edith Pomarol-Clotet, MD, PhD, FIDMAG Germanes Hospitalàries Research Foundation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
July 24, 2014
First Submitted That Met QC Criteria
July 25, 2014
First Posted (Estimate)
July 28, 2014
Study Record Updates
Last Update Posted (Estimate)
July 28, 2014
Last Update Submitted That Met QC Criteria
July 25, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PR-2009-15
- PI09/90483 (Other Identifier: Instituto de Salud Carlos III)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
University of Sao PauloUnknownRefractory Schizophrenia | Super Refractory SchizophreniaBrazil
-
Peking UniversityNot yet recruitingTreatment-resistant Schizophrenia
-
Rakitzi, StavroulaActive, not recruiting
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University Hospital, BrestRecruitingSchizophrenia | Schizophrenia Prodromal | Schizophrenia, ChildhoodFrance
Clinical Trials on Computer-assisted cognitive training
-
The Hong Kong Polytechnic UniversityCompletedCognitive Impairment | Executive Function | Efficacy | Schizophrenia; Psychosis | Randomized Controlled TrialHong Kong
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Cancer Survivor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of PennsylvaniaActive, not recruitingDepressive Disorder | Depression | Major Depressive Disorder | Depression, UnipolarUnited States
-
University of Maryland, BaltimoreNational Institute of Mental Health (NIMH); VISN 5 Mental Illness Research,...Completed
-
Washington University School of MedicineNational Institutes of Health (NIH)Completed
-
National Taiwan University HospitalCompleted
-
Stanford UniversityNational Cancer Institute (NCI)WithdrawnBreast Cancer | Cancer Survivor | Cognitive/Functional EffectsUnited States
-
Universidade Federal do Rio de JaneiroUnknown
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou UniversityWithdrawnStroke | Cognitive Impairment | DysphagiaChina
-
MuhammadNot yet recruiting